NanoViricides, Inc.

General ticker "NNVC" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $27.1M (TTM average)

NanoViricides, Inc. follows the US Stock Market performance with the rate: 34.3%.

Estimated limits based on current volatility of 3.1%: low 1.32$, high 1.39$

Factors to consider:

  • Total employees count: 7 (0.0%) as of 2025
  • Company does not operate outside US (retrieved using AI)
  • Top business risk factors: Operational and conduct risks, Need additional capital, Regulatory and compliance, Limited drug development experience, Third-party risks
  • Price in estimated range
  • Earnings for 3 months up through Q1 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2026-06-30 to 2028-06-29

  • 2026-06-30 to 2027-06-30 estimated range: [0.87$, 1.55$]
  • 2027-06-30 to 2028-06-29 estimated range: [0.82$, 1.47$]

Similar symbols

Short-term NNVC quotes

Long-term NNVC plot with estimates

Financial data

YTD 2024-06-30 2025-06-30 2026-06-30
Operating Revenue $0.00MM $0.00MM $0.00MM
Operating Expenses $8.52MM $9.59MM $8.31MM
Operating Income $-8.52MM $-9.59MM $-8.31MM
Non-Operating Income $0.22MM $0.12MM $0.09MM
Interest Expense $0.05MM $0.00MM $0.00MM
R&D Expense $5.44MM $5.55MM $4,707,625.00MM
Income(Loss) $-8.29MM $-9.47MM $-8.22MM
Net Income(Loss)* $-8.29MM $-9.47MM $8,218,492.56MM
Stockholders Equity $11.46MM $7.52MM $8,682,890.00MM
Assets $12.82MM $8.82MM $9,873,614.00MM
Operating Cash Flow $-6.32MM $-8.48MM $-7,696,015.00MM
Capital expenditure $0.16MM $0.06MM $84,317.00MM
Investing Cash Flow $-0.16MM $-0.06MM $-84,317.00MM
Financing Cash Flow $3.12MM $5.30MM $9,015,878.00MM
Earnings Per Share** $-0.70 $-0.63 $407,097.91

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.